prescription drugs

President Donald Trump speaks about kidney health at the Ronald Reagan Building and International Trade Center, accompanied by Health and Human Services Secretary Alex Azar, left, Wednesday, July 10, 2019, in Washington. (AP Photo/Alex Brandon)
July 11, 2019 - 5:08 pm
WASHINGTON (AP) — After two setbacks this week, President Donald Trump is now focusing his drive to curb drug costs on congressional efforts aimed at helping people on Medicare and younger generations covered by workplace plans. The White House on Thursday yanked its own regulation to ease the...
Read More
FILE - In this Oct. 25, 2018, file photo, President Donald Trump talks about drug prices during a visit to the Department of Health and Human Services in Washington. A federal judge Monday, July 8, 2019, blocked a major White House initiative on prescription drug costs, saying the Trump administration lacked the legal authority to require drugmakers to disclose their prices in TV ads. (AP Photo/Susan Walsh, File)
July 08, 2019 - 9:51 pm
WASHINGTON (AP) — A federal judge Monday blocked a major White House initiative on prescription drug costs, saying the Trump administration lacked the legal authority to require drugmakers to disclose their prices in TV ads. The narrow ruling by U.S. District Judge Amit Mehta in Washington, D.C.,...
Read More
In this June 20, 2019 photo, the Capitol is seen from the roof of the Canadian Embassy in Washington. Health care is on the agenda for Congress when lawmakers return, and it’s not another battle over the Obama-era Affordable Care Act. Instead of dealing with the uninsured, lawmakers are trying to bring down costs for people who already have coverage. (AP Photo/J. Scott Applewhite)
July 07, 2019 - 8:00 am
WASHINGTON (AP) — Lawmakers are trying to set aside their irreconcilable differences over the Obama-era Affordable Care Act and work to reach bipartisan agreement on a more immediate health care issue, lowering costs for people who already have coverage. Returning from their Fourth of July recess,...
Read More
FILE – In this Jan. 11, 2018, file photo, U.S. District Judge Dan Polster poses for a portrait in his office in Cleveland. Polster is holding a hearing Tuesday, June 25, 2019, in Cleveland on a plan pitched by lawyers for local governments on distributing money to nearly 25,000 municipal and county governments. The plan would take effect if companies that make and distribute the powerful prescription painkillers agree to one or more legal settlements. (AP Photo/Tony Dejak, File)
June 25, 2019 - 8:22 am
CLEVELAND (AP) — Tension is emerging between lawyers representing state and local governments over the path forward in a set of lawsuits seeking to hold the drug industry accountable for the toll of the nation's opioid crisis. A federal judge scheduled a hearing Tuesday in Cleveland on a plan...
Read More
FILE - In this Aug. 17, 2018 file photo, family and friends who lost loved ones to opioid overdoses protest outside the headquarters of Purdue Pharma, maker of the maker of painkiller OxyContin, in Stamford, Conn. The World Health Organization notified U.S. lawmakers Wednesday, June 19, 2019, that it will discontinue two publications on opioid painkiller prescribing, in response to allegations that the pharmaceutical industry influenced the reports. The pledge to remove the guidelines - viewed around the world as best practices in public health - comes a month after U.S. Reps. Katherine Clark and Hal Rogers accused the WHO of being influenced by Purdue. The lawmakers’ report claimed the guidelines were crafted by organizations with financial ties to the company, who worked to downplay risks addiction and overstate the benefits of opioids. Purdue has denied the allegations. (AP Photo/Jessica Hill, File)
June 19, 2019 - 8:03 pm
The World Health Organization has notified U.S. lawmakers that it will discontinue two publications on prescribing opioid painkillers in response to allegations that the pharmaceutical industry influenced the reports. The pledge to remove the guidelines comes a month after U.S. Reps. Katherine...
Read More
May 21, 2019 - 5:12 am
Authorities say a suburban Kansas City teen was killed when an $8 Xanax deal fell through. The Kansas City Star reports that the affidavit released Monday in the case against Matthew Lee Bibee Jr. says 17-year-old Rowan Padgett was killed in March after Bibee arranged to buy the anxiety medication...
Read More
Rep. Anna Eshoo, D-Calif., right, chair of the House Health Subcommittee, says President Donald Trump and Attorney General William Barr want to take a sledgehammer to health care, as she joins, from left, Rep. Lisa Blunt Rochester, D-Del., House Speaker Nancy Pelosi, D-Calif., and Senate Minority Leader Chuck Schumer, D-N.Y., at a Democratic event ahead of a House floor vote on the Health Care and Prescription Drug Package, at the Capitol in Washington, Wednesday, May 15, 2019. (AP Photo/J. Scott Applewhite)
May 16, 2019 - 7:07 pm
WASHINGTON (AP) — Democrats pushed legislation buttressing the 2010 health care law and curbing prescription drug prices through the House Thursday, advancing a bill that has no chance of surviving in the Senate or getting President Donald Trump's signature and seemed engineered with next year's...
Read More
FILE - In this March 13, 2019, file phtooHealth and Human Services Secretary Alex Azar testifies before a House Appropriations subcommittee on Capitol Hill in Washington. Azar says drugmakers will soon have to reveal prices of their prescription medicines in those ever-present TV ads. The Trump administration will issue final regulations on May 8 requiring drug companies to disclose list prices of medications costing more than $35 for a month’s supply. Azar tells The Associated Press if drugmakers are scared to put prices in ads that means they should lower those prices. (AP Photo/Susan Walsh, File)
May 08, 2019 - 9:01 am
WASHINGTON (AP) — Those ever-present TV ads for prescription drugs will soon carry prices, too, the nation's top health official said Wednesday, responding to a public outcry for government action to restrain medication costs. Health and Human Services Secretary Alex Azar said the Trump...
Read More
In this Friday, April 26, 2019 photo, a box of RELPAX migraine pills manufactured by Pfizer are arranged for a photo in Doral, Fla. Pfizer Inc. reports financial results Tuesday, April 30. (AP Photo/Wilfredo Lee)
April 30, 2019 - 2:27 pm
Higher prescription drugs sales and restrained spending together gave drugmaker Pfizer a 9% jump in first quarter profit as it easily topped analysts' profit expectations. Investors drove up Pfizer shares $1.20, or 3%, to $40.79 in early afternoon trading. Sales of breast cancer drug Ibrance and...
Read More
Prime Therapeutics Senior Vice President, General Counsel, and Interim President and Chief Executive Officer Mike Kolar, right, testifies before the Senate Finance Committee on Capitol Hill in Washington, Tuesday, April 9, 2019, during a hearing to explore the high cost of prescription drugs. He is joined at the table by, from left, Cigna Corporation Executive Vice President and Chief Clinical Officer Steve Miller, CVS Caremark President and CVS Health Executive Vice President Derica Rice, Humana Healthcare Services Segment President William Fleming and OptumRx Chief Executive Officer John Prince. (AP Photo/Susan Walsh)
April 09, 2019 - 1:29 pm
Patient bills, competition and secrecy shared the spotlight Tuesday as pharmacy benefit managers testified before Congress about prescription drug prices. Members of a Senate Finance Committee investigating drug costs pushed the benefit managers to explain why they can't do more to control prices...
Read More

Pages